Our new research study on “Veterinary Vaccines Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Vaccine Type and Technology,” the market is projected to reach US$ 15,536.38 million in 2028 from US$ 9,984.65 million in 2021; it is estimated to register a CAGR of 6.5% from 2021 to 2028.
The global veterinary vaccines market, based on technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and others. In 2021, the live attenuated vaccines segment is likely to hold the largest market share. However, the inactivated vaccines segment is expected to grow at the highest CAGR from 2021 to 2028.
The following manufacturers are covered: Boehringer Ingelheim International GmbH, MERCK, Zoetis Services LLC, Elanco, Vetoquinol, Ceva, Virbac, NEOGEN Corporation, Biovac, ImmuCell Corporation
Request a sample copy of this report @ https://www.theinsightpartners.com/sample/TIPRE00003539/
The report highlights trends existing in the market, and drivers and hindrances pertaining to the market growth. The companion animal category is predicted to increase at the highest rate because of the high frequency with which these animals come into contact with people and the fact that illnesses such as rabies can harm humans as well. Additionally, a boost in the adoption of these companion animals and increased knowledge of the need for dog and cat vaccinations contribute to the market's growth. Cats and dogs receive companion animal immunizations. Vaccines for livestock are frequently administered to farm animals. In 2020, the livestock vaccination market held the largest market share. The reason for this is that these animals are routinely vaccinated more frequently than companion animals. Besides, the segment's quick rise has been attributed to the rapid expansion of companion animal vaccinations, advancements in diagnostic services and vaccine technology, and worries over vaccine safety. Additionally, the industry is benefited by improving immunization regimens in response to changing disease patterns and the pet population. Thus, the benefits of veterinary vaccines are expected to drive the segment during the forecast period.
By Vaccine Type [Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines) and Companion Animal Vaccines (Feline Vaccines, Canine Vaccines, and Others)]
By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and Others)
Key Elements that the report acknowledges:
- Market size and growth rate during forecast period.
- Key factors driving the “Veterinary Vaccines” market.
- Key market trends cracking up the growth of the “Veterinary Vaccines” market.
- Challenges to market growth.
- Key vendors of “Veterinary Vaccines” market.
- Detailed SWOT analysis.
- Opportunities and threats faces by the existing vendors in Global “Veterinary Vaccines” market.
- Trending factors influencing the market in the geographical regions.
- Strategic initiatives focusing the leading vendors.
- PEST analysis of the market in the five major regions.
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defence, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
